Dr. Barish H. Edil
Dr. Edil is a graduate of the University of Wisconsin. He holds a Bachelor in Science degree in Zoology and received his Doctor of Medicine from the University of Wisconsin School of Medicine. Upon graduation, he received his graduate medical education with his Residency in General Surgery, followed by his Research Fellowship in Surgical Oncology at the University of Oklahoma College of Medicine. After completing his Residency Training in General Surgery, he continued his career as the Assistant Chief of Service at The Johns Hopkins University School of Medicine, receiving a certificate in Surgical Oncology. In addition, he completed his Postdoctoral Training in Cancer Immunology at The Johns Hopkins University School of Medicine. After completion of his training, he remained at The Johns Hopkins School of Medicine as an Assistant Professor for the Department of Surgery and the Department of Oncology. While on the faculty, he performed the first Laparoscopic Pancreaticoduodenectomy (“Whipple”) operation in the history of The Johns Hopkins Hospital. In addition, he ran the first Neoadjuvant Pancreatic Cancer Vaccine Trial.
He later joined the University of Colorado as the Division Chief of Surgical Oncology. In addition, while at the University of Colorado, Dr. Edil’s team discovered a new cancer vaccine, which is currently being developed for clinical trials.
Dr. Edil has authored more than 100 peer-reviewed articles and book chapters in leading surgery textbooks. He has been an invited lecturer in the field of Surgery, most notably in the areas of Laparoscopic Whipple surgery, Minimally Invasive Surgical Oncology, and Cancer Immunology. He is a Fellow of the American College of Surgeons and is active in a number of national societies and review groups/study sections.